Chas Bountra
Professor of Translational Medicine, Nuffield Department of Clinical Medicine, University of Oxford
Meet Chas Bountra
Before returning to Oxford, Chas was Vice President and Head of Biology at GlaxoSmithKline. He was involved in the identification of more than 40 clinical candidates for many gastro-intestinal, inflammatory and neuro-psychiatric diseases. More than 20 of these molecules progressed to patient studies, and over five progressed to late stage development. “Pharma is building increasingly porous relations with academia. I am sure this will foster a broader appreciation of the difficulties we face, change the reputation of the industry for the better, and accelerate the development of novel medicines for society.”